Cristina L Ronchi

🚨 The #ENSAT is thrilled and honoured to announce the senior speakers for the 1st #Educational Webinar on 27/02/2026 on topic #Genetic Breakthroughs in #AdrenalTumours!
🔔 Registration OPEN for everyone.
ℹ️ Programme & registration:
ensat.org/event-6456168
#EndoSky #MedSky

🚨 The #ENSAT is pleased to announce the chairs for the 1st Webinar scheduled on 27/02/2026.
Topiic will be #Genetic Breakthroughs in #AdrenalTumours.
🔔 Registration now OPEN for everyone.
ℹ️ Full programme & registration link:
ensat.org/event-6456168
#EndoSky #MedSky

A pleasure and a honour to host past #ENS@T President Prof Guillaume Assie from @hopitalcochin.bsky.social in Paris at @unibirmingham.bsky.social
Great opportunity to hear him talking about #genomics 🧬 in #endocrinetumours #adrenaltumours 👏and #networking with our #adrenal team!

🚨 Good news! Registrations are open for our 1st #educational Webinar on latest advances in #genetics of #adrenal #tumours. Expect lectures from excellent international speakers and case presentations from early careers. Programme & links: ensat.org/event-6456168 #EndoSky #MedSky

🎄Another well deserved Christmas dinner for our multidisciplinary @unibirmingham.bsky.social #adrenal team #thaifood #Christmas2025 #ChristmasVibes 🎄#team-building #teamscience #teamwork #EndoSky

‼️Don’t forget to register to @unibirmingham.bsky.social #SIMBA #Adrenal 2026. A great #educational opportunity on #adrenaldiseases. Great national & international experts. Endorsed by @socendocrinology.bsky.social & #ENS@T. #EndoSky #MedSky
Programme & registration: sites.google.com/view/simbasi...

The publication of the EndoCompass Research Roadmap marks a major milestone for endocrine science. It was a real community effort, involving:

🧠 228 experts
💡 10 specialist partners
🙋‍♀️ 8 patient advocacy groups

Thank you to everyone who contributed!

academic.oup.com/ejendo/issue/193/Supplement_2

Prolonged Mitotane Administration in Metastatic Adrenocortical Carcinoma With Over a Decade of Survival: A Case Series Background Reports of long-survival patients (>10 years) with metastatic adrenocortical carcinoma (ACC) and prolonged treatment with mitotane alone (>5 years) are rare. We present four patients trea.....

Well done visiting fellow Lorenzo Tucci @lrnztx.bsky.social & members of our @unibirmingham.bsky.social & UHB NHS Trust #Adrenal Multidisciplinary Team for publishing this case series of long-#adrenalcancer survivors treated with #mitotane #EndoSky #MedSky

onlinelibrary.wiley.com/doi/full/10....

Register now for #ECE2026

📆9-12 May 2026
📍Prague, Czech Republic

and save with our Super Early Bird registration fees
👉 ow.ly/FLX850XlBCS

🚨 SAVE THE DATE: the ENS@T Educational Team is pleased to announce the newly established ENS@T Webinars coming in 2026! 1st edition on 27/02/2026 about #Genetic Breakthroughs in #AdrenalTumours. Free registration will open soon only for #ENS@T members. Mark your calendars and stay tuned for details.

Cool 😎

Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study Even in specialised centres, cCS diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes. Ectopic cCS showed the mo...

Even in specialised centres, cyclic #Cushing's syndrome (cCS) diagnosis and management remain challenging with high rates of spontaneous #adrenal #insufficiency, inappropriate surgeries, and poor outcomes www.thelancet.com/journals/lan...
cyclic #Cushing's syndrome #cCS

#MedSky #EndoSky

Where are the biggest gaps in adrenal and cardiovascular endocrinology?

The second paper in the EndoCompass Research Roadmap outlines future research priorities.

Read the full findings 👉 doi.org/10.1093/ejen...

A great pleasure and honour to represent the @unibirmingham.bsky.social adrenal team and the #ENS@T at the @sociedadseen.bsky.social #SEEN2025 in #Granada and talk about molecular studies in clinical practice for #adrenalcancer #adrenocorticalcarcinoma #adrenalresearch #MedSky #EndoSky

Final call for patients with adrenocortical carcinoma (ACC) to join us tomorrow for this webinar

Translations into French, German & Italian available.

📅4 October, 10:00-13:00 CEST

Register 👉 ow.ly/ERAh50W6CAy

Great time at #ISP2025 in Montréal representing the #ENSAT community together with many others. Honoured to present our @unibirmingham.bsky.social project on #machinelearning #webapp for prediction of #metastasis in #pheo #PPGL 🙏 to the LOC for organising an amazing event! #EndoSky #MedSky #adrenal

Impressions from the joint final EU Cost Action Harmonisation conference & 24th #ENSAT2025 annual meeting in Belgrade! It has been a great success with 230 participants from all over the world. Huge thanks to LOC chair @ljiljanamarina.bsky.social and team, and all the ENS@T ExCo for excellent job.

Another great day yesterday at the ENS@T annual conference with more talks and posters from our @unibirmingham.bsky.social #Adrenal team #ENSAT2025 👏👏👏 #EndoSky

Excellent representation of our @unibirmingham.bsky.social Adrenal Team at the #adrenalcancer oral session at #ENSAT2025 annual meeting in #Belgrade! Well done everyone 👏👏 #EndoSky

Impression of the amazing final Masterclass of the EU Cost Action Harmonisation and reception today in #Belgrade! Well done to the LOC and the Harmonisation team 👏 #adrenaltumour #networking #education #teamwork

A great start in #Belgrade! Thank you @ljiljanamarina.bsky.social & Antoan Soat for the invitation to give a talk on prognostication of #adrenalcancer the #AdvanceAdrenal national symposium! Looking forward to the last EU Cost Action Harmonisation asterclass starting tomorrow! #EndoSky #MedSky

Patients with adrenocortical carcinoma (ACC), this webinar is for you!

Our clinical experts will discuss 'Living with Adrenocortical Carcinoma: Care, Support and What's Ahead'.

Translations into French, German and Italian.

📅4 October, 10:00-13:00 CEST

Register now for free!
👉 ow.ly/ERAh50W6CAy

Graphic featuring the For Women in Science logo and dark blue circles against an image of a female scientist in the background. Text reads: "L’Oréal-UNESCO For Women in Science UK and Ireland Young Talent Awards - Apply by Wednesday, 20 August 2025".

Are you a postdoctoral female scientist? You could be awarded a £25,000 flexible grant towards advancing your research through the L’Oréal-UNESCO For #WomenInScience UK and Ireland Young Talent Awards.🔬👩‍🔬

Apply online👉 ow.ly/INSS50WzRgM

The application deadline is Wednesday, 20 August at 23:59pm.📅

The #ENS@T Executive Committee is excited to announce the program of the joint final EU #CostAction Harmonis@tion & 24th ENS@T scientific meeting 3-5 Sep 2025 in #Belgrade available at ensat.org! Thanks to the amazing LOC @ljiljanamarina.bsky.social
and team! 👏 #adrenal #adrenaltumours #EndoSky

Endocrine health in survivors of adult-onset cancer Long-term survivors of cancer (ie, the patient who is considered cured or for whom the disease is under long-term control and unlikely to recur) are at an increased risk of developing endocrine compli...

Endocrine complications occur in 40–60% of survivors of cancer and include hypothalamic–pituitary disorders, dysregulation of steroid and peptide hormones, and dysregulation of bone and metabolism www.thelancet.com/journals/lan...
#OpenAccess

#MedSky #EndoSky #OncSky

Adrenocortical carcinoma: a practical guide for clinicians Adrenocortical carcinoma is a rare endocrine malignancy. The management of patients with adrenocortical carcinoma is challenging for several reasons, including its heterogeneous but frequently aggress...

Adrenocortical carcinoma poses unique challenges to physicians, who must tackle both tumour progression and hormone secretion, and it considerably affects life expectancy www.thelancet.com/journals/lan... #ACC
#OpenAccess

#MedSky #EndoSky #OncSky

Only 2 months to go! Don’t miss the chance to register to our virtual @unibirmingham.bsky.social Adrenal Tumour Masterclass. Endorsed by @socendocrinology.bsky.social accredited @royalcollege.bsky.social 6 CPD points. Expert speakers and interactive MCQ. Topic #adrenalcancer #EndoSky #MedSky

A green graphic with text: "European Society of Endocrinology (ESE) Adrenal Patient Forum. Webinar for Patients with Adrenocortical Carcinoma. 4 October 2025, 10:00-13:00 CEST. Join us for the virtual event 'Living with Adrenocortical Carcinoma (ACC): Care, Support, and What's Ahead' to hear from clinical experts and patients from across Europe. www.ese-hormones.org/adrenalpatientforum2025. Register now! This event is kindly supported by Recordati Rare Diseases."

Registration now open! Join @ESEndocrinology for 'Living with Adrenocortical Carcinoma (ACC)' to hear clinical experts and patients alike.

-Saturday, 4 October 2025
-10:00–13:00 CEST
-In English with simultaneous translations into French, German and Italian

ese-hormones.org/adrenalpatientforum2025

Our latest clinical practice guideline, Primary Aldosteronism (bit.ly/44MbrSv), is now available. The new guideline recommends more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism. Read in @endocrinenews.bsky.social: bit.ly/4kFadhv #ENDO2025

A figure showing the changes from baseline in systolic blood pressure (SBP), plasma aldosterone–renin ratio (ARR), and serum potassium level for each patient.

In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results: nej.md/40Js1kz

#ENDO2025